Clinical Trials Directory

Trials / Conditions / Telangiectasia

Telangiectasia

15 registered clinical trials studyying Telangiectasia2 currently recruiting.

StatusTrialSponsorPhase
CompletedEvaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea
NCT06582043
NAOS Argentina S.A.N/A
RecruitingComprehensive HHT Outcomes Registry of the United States (CHORUS)
NCT06259292
Cure HHT
CompletedEfficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence
NCT05978986
Clinic of Phlebology and Laser Surgery, Chelyabinsk, RussiaN/A
TerminatedSkin Imaging to Inform Laser Treatments
NCT04336163
University of California, IrvineN/A
CompletedPilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Sy
NCT05036200
University Hospital, CaenN/A
CompletedClinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial Telangiectasia
NCT04795310
Xijing HospitalN/A
RecruitingPartial Breast Versus no Irradiation for Women With Early Breast Cancer
NCT03646955
Danish Breast Cancer Cooperative GroupN/A
CompletedD-OCT of Facial Telangiectasia Treated With IPL
NCT04274842
Zealand University HospitalN/A
CompletedTreatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser
NCT03472859
Tampere University HospitalN/A
CompletedUltherapy for the Treatment of Spider Veins on the Legs
NCT02286804
Ulthera, IncN/A
CompletedEffects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Di
NCT04148950
Istanbul UniversityN/A
CompletedStudy of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte
NCT01491620
Cutera Inc.N/A
CompletedInjected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
NCT00457145
National Eye Institute (NEI)Phase 1
CompletedInjected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
NCT00457067
National Eye Institute (NEI)Phase 1
CompletedRanibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
NCT00378196
Johns Hopkins UniversityPhase 1